Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice

<div>The image of tail-base wound in mice. Negative control (without treatment) vs. positive control (treatment with glucantime) and the ointment group (treatment with luteolin/AgNPQct ointment) on 1, 7, 14, and 21 days.</div>

Advances in Materials Science and Engineering

fig4

Figure 4

Figure 4: Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice 

Figure 4 | Topically Applied Luteolin /Quercetin-Capped Silver Nanoparticle Ointment as Antileishmanial Composite: Acceleration Wound Healing in BALB/c Mice 